Nominal providers hardware testing equipment to defense tech companies. Founders Fund led the preemptive deal.

Despite efforts by test maker Grail to highlight outcomes the company considers positive, some experts are warning against using the Galleri test and others like it.

Biomarker testing helps doctors create personalized cancer treatments with fewer side effects. Many health insurers deny coverage for this testing, calling it "experimental." Lack of insurance ...

Airbnb plans to double down on artificial intelligence to improve its user experience for both guests and hosts. During a fourth-quarter earnings call, Airbnb's CEO, Brian Chesky, said the company is ...

Alnoor Ebrahim does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

State lawmakers are looking at a new bill that would require Medicaid and private insurance providers to cover biomarker testing for cancer patients. Biomarker testing can identify what type of cancer ...

Personalis shares rose after the company received Medicare coverage for its NeXT Personal molecular residual disease test for surveillance of patients with Stage I to III non-small cell lung cancer.

Personalis, Inc. PSNL stock is up in Tuesday’s premarket session after the company received Medicare coverage for its NeXT Personal molecular residual disease test for lung cancer surveillance. This ...

The news from around the region, the nation and the world. Authorities release videos, photos of 'potential subject' in Nancy Guthrie case Khanna reads names of 6 men 'likely incriminated' in Epstein ...

or on the link below. This OMA Position Statement is intended to provide a preliminary overview of emerging policies regarding Medicare and Medicaid coverage of obesity medications, as well as ...

When Asian American Olympians Chloe Kim and Eileen Gu competed in their first Winter Games, they were treated differently by the U.S. media, a new University of Michigan study suggests. Snowboarder ...

As the therapeutic reach of glucagon-like peptide-1 receptor agonists (GLP-1s) expands -- with the potential to reduce not just obesity but also a range of obesity-related diseases -- the Obesity ...